Outcome of Medically Versus Surgically Treated Patients With Chronic Thromboembolic Pulmonary Hypertension.
Saved in:
| Title: | Outcome of Medically Versus Surgically Treated Patients With Chronic Thromboembolic Pulmonary Hypertension. |
|---|---|
| Authors: | Wieteska M; Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, Otwock, Poland mwiet@poczta.onet.pl., Biederman A; Department of Cardiac Surgery, Allenort Hospital, Warsaw, Poland., Kurzyna M; Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, Otwock, Poland., Dyk W; Department of Cardiac Surgery, Allenort Hospital, Warsaw, Poland., Burakowski J; Intensive Pneumo-Cardiological Treatment Unit, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland., Wawrzyńska L; Institute of Tuberculosis and Lung Diseases, Warsaw, Poland., Szturmowicz M; First Pulmonary Department, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland., Fijałkowska A; Department of Cardiology, Institute of Mother and Child, Warsaw, Poland., Szatkowski P; Department of Anesthesiology, Institute of Cardiology, Warsaw-Anin, Poland., Torbicki A; Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, Otwock, Poland. |
| Source: | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2016 Jan; Vol. 22 (1), pp. 92-9. Date of Electronic Publication: 2014 May 28. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 9508125 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2723 (Electronic) Linking ISSN: 10760296 NLM ISO Abbreviation: Clin Appl Thromb Hemost Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
